Literature DB >> 17222948

Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1.

I Dewachter1, L Ris, S Croes, P Borghgraef, H Devijver, T Voets, B Nilius, E Godaux, F Van Leuven.   

Abstract

The function of presenilin1 (PS1) in intra-membrane proteolysis is undisputed, as is its role in neurodegeneration in FAD, in contrast to its exact function in normal conditions. In this study, we analyzed synaptic plasticity and its underlying mechanisms biochemically in brain of mice with a neuron-specific deficiency in PS1 (PS1(n-/-)) and compared them to mice that expressed human mutant PS1[A246E] or wild-type PS1. PS1(n-/-) mice displayed a subtle impairment in Schaffer collateral hippocampal long-term potentiation (LTP) as opposed to normal LTP in wild-type PS1 mice, and a facilitated LTP in mutant PS1[A246E] mice. This finding correlated with, respectively, increased and reduced NMDA receptor responses in PS1[A246E] mice and PS1(n-/-) mice in hippocampal slices. Postsynaptically, levels of NR1/NR2B NMDA-receptor subunits and activated alpha-CaMKII were reduced in PS1(n-/-) mice, while increased in PS1[A246E] mice. In addition, PS1(n-/-) mice, displayed reduced paired pulse facilitation, increased synaptic fatigue and lower number of total and docked synaptic vesicles, implying a presynaptic function for wild-type presenilin1, unaffected by the mutation in PS1[A246E] mice. In contrast to the deficiency in PS1, mutant PS1 activated GSK-3beta by decreasing phosphorylation on Ser-9, which correlated with increased phosphorylation of protein tau at Ser-396-Ser-404 (PHF1/AD2 epitope). The synaptic functions of PS1, exerted on presynaptic vesicles and on postsynaptic NMDA-receptor activity, were concluded to be independent of alterations in GSK-3beta activity and phosphorylation of protein tau.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222948     DOI: 10.1016/j.neurobiolaging.2006.11.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

2.  Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration.

Authors:  Tomasz Jaworski; Benoit Lechat; David Demedts; Lies Gielis; Herman Devijver; Peter Borghgraef; Hans Duimel; Fons Verheyen; Sebastian Kügler; Fred Van Leuven
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

3.  Improved preparation and preservation of hippocampal mouse slices for a very stable and reproducible recording of long-term potentiation.

Authors:  Agnès Villers; Laurence Ris
Journal:  J Vis Exp       Date:  2013-06-26       Impact factor: 1.355

4.  Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.

Authors:  Hien T Tran; Frank M LaFerla; David M Holtzman; David L Brody
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

5.  Presenilin-1 regulates the expression of p62 to govern p62-dependent tau degradation.

Authors:  Ying-Tsen Tung; Bo-Jeng Wang; Wen-Ming Hsu; Ming-Kuan Hu; Guor Mour Her; Wei-Pang Huang; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-06-23       Impact factor: 5.590

6.  Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice.

Authors:  Simon Gengler; Alison Hamilton; Christian Hölscher
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

7.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

8.  Modeling presenilin-dependent familial Alzheimer's disease: emphasis on presenilin substrate-mediated signaling and synaptic function.

Authors:  Angèle T Parent; Gopal Thinakaran
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

9.  Aging of the NMDA receptor: from a mouse's point of view.

Authors:  Kathy R Magnusson
Journal:  Future Neurol       Date:  2012-09

Review 10.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.